SEARCH

SEARCH BY CITATION

References

  • Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H. (2009) Purinergic signalling in the nervous system: an overview. Trends Neurosci 32:1929.
  • Araki T, Simon RP, Taki W, Lan JQ, Henshall DC. (2002) Characterization of neuronal death induced by focally evoked limbic seizures in the C57BL/6 mouse. J Neurosci Res 69:614621.
  • Arbeloa J, Perez-Samartin A, Gottlieb M, Matute C. (2012) P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia. Neurobiol Dis 45:954961.
  • Armstrong JN, Brust TB, Lewis RG, MacVicar BA. (2002) Activation of presynaptic P2X7-like receptors depresses mossy fiber-CA3 synaptic transmission through p38 mitogen-activated protein kinase. J Neurosci 22:59385945.
  • Avignone E, Ulmann L, Levavasseur F, Rassendren F, Audinat E. (2008) Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling. J Neurosci 28:91339144.
  • Bernhardt BC, Bernasconi N, Concha L, Bernasconi A. (2009) Cortical thickness analysis in temporal lobe epilepsy: reproducibility and relation to outcome. Neurology 74:17761784.
  • Burnstock G. (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659797.
  • Curia G, Longo D, Biagini G, Jones RS, Avoli M. (2008) The pilocarpine model of temporal lobe epilepsy. J Neurosci Methods 172:143157.
  • Dale N, Frenguelli BG. (2009) Release of adenosine and ATP during ischemia and epilepsy. Curr Neuropharmacol 7:160179.
  • Deuchars SA, Atkinson L, Brooke RE, Musa H, Milligan CJ, Batten TF, Buckley NJ, Parson SH, Deuchars J. (2001) Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J Neurosci 21:71437152.
  • Diaz-Hernandez M, Diez-Zaera M, Sanchez-Nogueiro J, Gomez-Villafuertes R, Canals JM, Alberch J, Miras-Portugal MT, Lucas JJ. (2009) Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration. FASEB J 23:18931906.
  • Diaz-Hernandez JI, Gomez-Villafuertes R, Leon-Otegui M, Hontecillas-Prieto L, Del Puerto A, Trejo JL, Lucas JJ, Garrido JJ, Gualix J, Miras-Portugal MT, Diaz-Hernandez M. (2012) In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3beta and secretases. Neurobiol Aging 33:18161828.
  • Engel T, Caballero-Caballero A, Schindler CK, Plesnila N, Strasser A, Prehn JH, Henshall DC. (2010a) BH3-only protein Bid is dispensable for seizure-induced neuronal death and the associated nuclear accumulation of apoptosis-inducing factor. J Neurochem 115:92101.
  • Engel T, Murphy BM, Hatazaki S, Jimenez-Mateos EM, Concannon CG, Woods I, Prehn JH, Henshall DC. (2010b) Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic Puma. FASEB J 24:853861.
  • Engel T, Gomez-Villafuertes R, Tanaka K, Mesuret G, Sanz-Rodriguez A, Garcia-Huerta P, Miras-Portugal MT, Henshall DC, Diaz-Hernandez M. (2012a) Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice. FASEB J 26:16161628.
  • Engel T, Jimenez-Pacheco A, Miras-Portugal MT, Diaz-Hernandez M, Henshall DC. (2012b) P2X7 receptor in epilepsy; role in pathophysiology and potential targeting for seizure control. Int J Physiol Pathophysiol Pharmacol 4:174187.
  • Engel T, Sanz-Rodgriguez A, Jimenez-Mateos EM, Concannon CG, Jimenez-Pacheco A, Moran C, Mesuret G, Petit E, Delanty N, Farrell MA, O'Brien DF, Prehn JH, Lucas JJ, Henshall DC. (2013) CHOP regulates the p53-MDM2 axis and is required for neuronal survival after seizures. Brain 136:577592.
  • Feng Z, Chang RC, Bing G, Hudson P, Tiao N, Jin L, Hong JS. (1999) Long-term increase of Sp-1 transcription factors in the hippocampus after kainic acid treatment. Brain Res Mol Brain Res 69:144148.
  • Fujikawa DG, Itabashi HH, Wu A, Shinmei SS. (2000) Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy. Epilepsia 41:981991.
  • Garcia-Huerta P, Diaz-Hernandez M, Delicado EG, Pimentel-Santillana M, Miras-Portugal MT, Gomez-Villafuertes R. (2012) The specificity protein factor Sp1 mediates transcriptional regulation of P2X7 receptors in the nervous system. J Biol Chem 287:4462844644.
  • Helmstaedter C. (2007) Cognitive outcome of status epilepticus in adults. Epilepsia 48(Suppl. 8):8590.
  • Herrera DG, Robertson HA. (1996) Activation of c-fos in the brain. Prog Neurobiol 50:83107.
  • Jimenez-Mateos EM, Engel T, Merino-Serrais P, McKiernan RC, Tanaka K, Mouri G, Sano T, O'Tuathaigh C, Waddington JL, Prenter S, Delanty N, Farrell MA, O'Brien DF, Conroy RM, Stallings RL, DeFelipe J, Henshall DC. (2012) Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat Med 18:10871094.
  • Kienzler F, Norwood BA, Sloviter RS. (2009) Hippocampal injury, atrophy, synaptic reorganization, and epileptogenesis after perforant pathway stimulation-induced status epilepticus in the mouse. J Comp Neurol 515:181196.
  • Kim JE, Kang TC. (2011) The P2X7 receptor-pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice. J Clin Invest 121:20372047.
  • Kimbler DE, Shields J, Yanasak N, Vender JR, Dhandapani KM. (2012) Activation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in mice. PLoS ONE 7:e41229.
  • Lin JJ, Salamon N, Lee AD, Dutton RA, Geaga JA, Hayashi KM, Luders E, Toga AW, Engel J Jr, Thompson PM. (2007) Reduced neocortical thickness and complexity mapped in mesial temporal lobe epilepsy with hippocampal sclerosis. Cereb Cortex 17:20072018.
  • McKiernan RC, Jimenez-Mateos EM, Bray I, Engel T, Brennan GP, Sano T, Michalak Z, Moran C, Delanty N, Farrell M, O'Brien D, Meller R, Simon RP, Stallings RL, Henshall DC. (2012) Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis. PLoS ONE 7:e35921.
  • Miras-Portugal MT, Diaz-Hernandez M, Giraldez L, Hervas C, Gomez-Villafuertes R, Sen RP, Gualix J, Pintor J. (2003) P2X7 receptors in rat brain: presence in synaptic terminals and granule cells. Neurochem Res 28:15971605.
  • Monif M, Reid CA, Powell KL, Smart ML, Williams DA. (2009) The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. J Neurosci 29:37813791.
  • Mouri G, Jimenez-Mateos E, Engel T, Dunleavy M, Hatazaki S, Paucard A, Matsushima S, Taki W, Henshall DC. (2008) Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice. Brain Res 1213:140151.
  • Rappold PM, Lynd-Balta E, Joseph SA. (2006) P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain. Brain Res 1089:171178.
  • Sperlagh B, Kofalvi A, Deuchars J, Atkinson L, Milligan CJ, Buckley NJ, Vizi ES. (2002) Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus. J Neurochem 81:11961211.
  • Sperlagh B, Vizi ES, Wirkner K, Illes P. (2006) P2X7 receptors in the nervous system. Prog Neurobiol 78:327346.
  • Surprenant A, North RA. (2009) Signaling at purinergic P2X receptors. Annu Rev Physiol 71:333359.
  • Thompson PJ, Duncan JS. (2005) Cognitive decline in severe intractable epilepsy. Epilepsia 46:17801787.
  • Vezzani A, French J, Bartfai T, Baram TZ. (2011) The role of inflammation in epilepsy. Nat Rev Neurol 7:3140.
  • Vianna EP, Ferreira AT, Naffah-Mazzacoratti MG, Sanabria ER, Funke M, Cavalheiro EA, Fernandes MJ. (2002) Evidence that ATP participates in the pathophysiology of pilocarpine-induced temporal lobe epilepsy: fluorimetric, immunohistochemical, and Western blot studies. Epilepsia 43(Suppl. 5):227229.
  • Wasterlain CG, Chen JW. (2008) Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia 49(Suppl. 9):6373.